Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Greetings, and welcome to Inhibikase Therapeutics Fourth Quarter and Full Year 2023 Financial Results.
Inhibikase Therapeutics Inc. (IKT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 24,422 | $31,000 | +52% | 0% |
| 2. | Armistice Capital Steven Boyd | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.80 | 5,000 | Large Shareholder, Officer, Director | 5,335,433 | 2022-08-16 | Filing | |
| $0.98 | 5,000 | Large Shareholder, Officer, Director | 5,330,433 | 2022-05-27 | Filing | |
| $0.60 | 10,000 | Large Shareholder, Officer, Director | 5,325,433 | 2022-05-20 | Filing | |
| $0.64 | 3,948 | Officer | 48,091 | 2022-05-19 | Filing | |
| $1.93 | 400 | Large Shareholder, Officer, Director | 23,589 | 2021-11-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 82,045 | $104,197 | 0% | |
| 2. | 60,268 | $76,540 | 0% | |
| 3. | 28,692 | $36,465 | 0% | |
| 4. | 19,644 | $24,948 | 0% | |
| 5. | 10,084 | $12,807 | 0% |
News See All
5 Cheap Small-Cap Stocks to Buy Before the Next Breakout
In this piece, we will take a look at five cheap small cap stocks to buy before the next breakout.
Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q2 2023 Earnings Call Transcript
Operator: Good morning. Welcome to the Inhibikase Therapeutics Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q1 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Inhibikase Therapeutics First Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.
Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2022 Earnings Call Transcript
Operator: Good morning and welcome to the Inhibikase Fourth Quarter and Full Year 2022 Earnings Conference Call. Please note, today's event is being recorded.
Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q3 2022 Earnings Call Transcript
Operator: Good day, and welcome to Inhibikase Therapeutics' Third Quarter 2022 Financial Results Conference Call. All participants are in listen-only mode. Please note, this event is being recorded.
Billionaire Hedge Funds
